These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2342072)

  • 1. Evolution of a series of peptidoleukotriene antagonists: synthesis and structure/activity relationships of 1,3,5-substituted indoles and indazoles.
    Matassa VG; Maduskuie TP; Shapiro HS; Hesp B; Snyder DW; Aharony D; Krell RD; Keith RA
    J Med Chem; 1990 Jun; 33(6):1781-90. PubMed ID: 2342072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolution of a series of peptidoleukotriene antagonists: synthesis and structure-activity relationships of 1,6-disubstituted indoles and indazoles.
    Brown FJ; Yee YK; Cronk LA; Hebbel KC; Krell RD; Snyder DW
    J Med Chem; 1990 Jun; 33(6):1771-81. PubMed ID: 2342071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1,3,6-trisubstituted indoles as peptidoleukotriene antagonists: benefits of a second, polar, pyrrole substituent.
    Brown FJ; Cronk LA; Aharony D; Snyder DW
    J Med Chem; 1992 Jun; 35(13):2419-39. PubMed ID: 1320123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The preclinical pharmacology of ICI 204,219. A peptide leukotriene antagonist.
    Krell RD; Aharony D; Buckner CK; Keith RA; Kusner EJ; Snyder DW; Bernstein PR; Matassa VG; Yee YK; Brown FJ
    Am Rev Respir Dis; 1990 Apr; 141(4 Pt 1):978-87. PubMed ID: 2158259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substituted 3-(phenylmethyl)-1H-indole-5-carboxamides and 1-(phenylmethyl)indole-6-carboxamides as potent, selective, orally active antagonists of the peptidoleukotrienes.
    Jacobs RT; Brown FJ; Cronk LA; Aharony D; Buckner CK; Kusner EJ; Kirkland KM; Neilson KL
    J Med Chem; 1993 Feb; 36(3):394-409. PubMed ID: 8381184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and in vitro LTD4 antagonist activity of bicyclic and monocyclic cyclopentylurethane and cyclopentylacetamide N-arylsulfonyl amides.
    Matassa VG; Brown FJ; Bernstein PR; Shapiro HS; Maduskuie TP; Cronk LA; Vacek EP; Yee YK; Snyder DW; Krell RD
    J Med Chem; 1990 Sep; 33(9):2621-9. PubMed ID: 2167983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro pharmacology of ICI 198,615: a novel, potent and selective peptide leukotriene antagonist.
    Snyder DW; Giles RE; Keith RA; Yee YK; Krell RD
    J Pharmacol Exp Ther; 1987 Nov; 243(2):548-56. PubMed ID: 2824751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of 3H-leukotriene D4 binding to guinea pig lung receptors by the novel leukotriene antagonist ICI 198,615.
    Aharony D; Falcone RC; Krell RD
    J Pharmacol Exp Ther; 1987 Dec; 243(3):921-6. PubMed ID: 2826761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding of radiolabeled high affinity antagonist to leukotriene D4 receptor in guinea pig lung membranes: interconversion of agonist-receptor binding affinity states.
    O'Sullivan BP; Mong S
    Mol Pharmacol; 1989 Jun; 35(6):795-802. PubMed ID: 2543913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of antigen-induced contraction of guinea pig trachea by ICI 198,615.
    Redkar-Brown DG; Aharony D
    Eur J Pharmacol; 1989 Jun; 165(1):113-21. PubMed ID: 2767127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical and pharmacological characterization of ICI 198,615: a peptide leukotriene receptor antagonist.
    Krell RD; Kusner EJ; Aharony D; Giles RE
    Eur J Pharmacol; 1989 Jan; 159(1):73-81. PubMed ID: 2565238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel series of selective leukotriene antagonists: exploration and optimization of the acidic region in 1,6-disubstituted indoles and indazoles.
    Yee YK; Bernstein PR; Adams EJ; Brown FJ; Cronk LA; Hebbel KC; Vacek EP; Krell RD; Snyder DW
    J Med Chem; 1990 Sep; 33(9):2437-51. PubMed ID: 2391686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-[(arylmethoxy)phenyl] carboxylic acids, hydroxamic acids, tetrazoles, and sulfonyl carboxamides. Potent orally active leukotriene D4 antagonists of novel structure.
    Musser JH; Kreft AF; Bender RH; Kubrak DM; Grimes D; Carlson RP; Hand JM; Chang J
    J Med Chem; 1990 Jan; 33(1):240-5. PubMed ID: 2104935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, structure-activity relationships, and pharmacological evaluation of a series of fluorinated 3-benzyl-5-indolecarboxamides: identification of 4-[[5-[((2R)-2-methyl-4,4,4-trifluorobutyl)carbamoyl]-1-methyl indol- 3-yl]methyl]-3-methoxy-N-[(2-methylphenyl)sulfonyl]benzamide, a potent, orally active antagonist of leukotrienes D4 and E4.
    Jacobs RT; Bernstein PR; Cronk LA; Vacek EP; Newcomb LF; Aharony D; Buckner CK; Kusner EJ
    J Med Chem; 1994 Apr; 37(9):1282-97. PubMed ID: 8176706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Competition of leukotrienes and ICI-198,615 for [3H]LTD4 binding sites in guinea pig lung membranes suggests the involvement of two LTD4 receptor subtypes.
    Shirley JT; Cheng JB
    J Pharmacol Exp Ther; 1991 Aug; 258(2):531-6. PubMed ID: 1650832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo pharmacology of ICI 198,615: a novel, potent and selective peptide leukotriene antagonist.
    Krell RD; Giles RE; Yee YK; Snyder DW
    J Pharmacol Exp Ther; 1987 Nov; 243(2):557-64. PubMed ID: 2824752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guanyl-5'-yl-lmidodiphosphate regulation of ligand binding to LTD4 receptors on guinea pig lung membranes.
    Catanese CA; Falcone RC; Aharony D
    J Pharmacol Exp Ther; 1989 Dec; 251(3):846-51. PubMed ID: 2557419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MDL 28,753, an agonist of LTD4 but an antagonist of LTC4 in longitudinal muscle of guinea pig ileum.
    Gieske TH; Sabol JS; Raddatz R
    J Pharmacol Exp Ther; 1990 Jul; 254(1):192-7. PubMed ID: 2164091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An examination of the influence of the epithelium on contractile responses to peptidoleukotrienes and blockade by ICI 204,219 in isolated guinea pig trachea and human intralobar airways.
    Buckner CK; Fedyna JS; Robertson JL; Will JA; England DM; Krell RD; Saban R
    J Pharmacol Exp Ther; 1990 Jan; 252(1):77-85. PubMed ID: 2153812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific binding of 3H-ICI 198,615, a potent LTD4 antagonist, to guinea pig cardiac ventricular membranes.
    Falcone RC; Orzechowski RF; Aharony D
    Prostaglandins; 1990 Mar; 39(3):241-58. PubMed ID: 2160091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.